Essential Premium

RA Capital’s SPAC Finds Partner

Hedge funds, including Balyasny Asset Management and Janus Henderson, are helping finance the deal.

More Than $1 Trillion Is Stuck in ‘Zombie’ Private Equity Funds

Managers “have been reluctant to shed below peak NAV because they've gotten accustomed to the marks that they saw four years ago.”

Sponsored

The Hidden Margin Drain: Why Manual Data Operations Are Becoming Too Expensive to Ignore

Haidar Overhauls Portfolio as Losses Mount

The volatile macro fund is trying to avoid its third loss in four years.

Related Content

Why Biotech Struggles to Finish What It Starts

Julie Segal

RA Capital Preps New Biotech SPAC — With an Eye on China’s Risks

Stephen Taub

Janus Henderson Maintains Its Wide Lead in Biotech

Steve Taub

1270 Avenue of the Americas, Suite 1100

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X (Twitter)
Bluesky
Instagram